Becton Dickinson (NYSE:BDX) announced that it acquired the medical business assets of software developer Cubex.
Privately-held Cubex develops cloud-based software offerings for advanced medication management, according to a news release. Becton Dickinson said the acquisition expands its medication management offerings into the care continuum space and offers deeper integration with electronic health records.
Cubex’s medical business’ main offering is its cloud-based software for decentralizing medication management, providing specialized features for pharmacists and nurses. The two companies have already worked together in a commercial distribution relationship.
“The Medical Business of Cubex prides itself on developing software and analytics for advanced medication management that focus on the needs of the pharmacist and nurse to help alleviate administrative burden while ensuring patient safety,” Cubex CEO Anton Visser said in the release. “By joining BD – a leading medtech company – we look forward to the expanded impact our solutions will have towards improved patient care.”
Franklin Lakes, N.J.-based Becton Dickinson said it will be taking approximately 40 Cubex associates on board, with terms of the transaction not disclosed. The company also said the purchase does not impact its fiscal 2021 guidance.
“This strategic acquisition brings together our industry-leading BD Pyxis automated dispensing cabinets with the medical business of Cubex’s MedBank cloud-based software and analytics platform to help enable patient-centered care beyond the acute care setting,” BD worldwide president of medication management Mike Garrison said. “We are committed to improving and connecting the medication management process across health care settings, and this acquisition allows us to help address the unique needs care continuum facilities face, from minimizing medication diversion to improving inventory management.”
